AdaptHealth Corp. (NASDAQ:AHCO) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of AdaptHealth Corp. (NASDAQ:AHCO) have earned an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and five have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $13.60.

A number of research firms recently weighed in on AHCO. Zacks Research raised AdaptHealth from a “strong sell” rating to a “hold” rating in a report on Thursday, January 1st. Wall Street Zen upgraded AdaptHealth from a “buy” rating to a “strong-buy” rating in a research report on Saturday, January 17th. Weiss Ratings downgraded AdaptHealth from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, January 15th. Finally, Canaccord Genuity Group lifted their price target on shares of AdaptHealth from $14.00 to $15.00 and gave the company a “buy” rating in a research note on Thursday, November 6th.

Insider Transactions at AdaptHealth

In other AdaptHealth news, Director David Solomon Williams III sold 5,000 shares of the stock in a transaction on Thursday, December 4th. The shares were sold at an average price of $9.43, for a total transaction of $47,150.00. Following the transaction, the director directly owned 45,045 shares of the company’s stock, valued at $424,774.35. This trade represents a 9.99% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 1.55% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of AHCO. AlphaQuest LLC boosted its holdings in AdaptHealth by 275.7% in the 2nd quarter. AlphaQuest LLC now owns 3,941 shares of the company’s stock worth $37,000 after buying an additional 2,892 shares during the last quarter. FNY Investment Advisers LLC purchased a new position in shares of AdaptHealth in the third quarter valued at approximately $35,000. Assetmark Inc. boosted its stake in shares of AdaptHealth by 87.6% in the second quarter. Assetmark Inc. now owns 5,529 shares of the company’s stock worth $52,000 after acquiring an additional 2,581 shares during the last quarter. Tower Research Capital LLC TRC boosted its stake in shares of AdaptHealth by 318.0% in the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after acquiring an additional 7,297 shares during the last quarter. Finally, Tidal Investments LLC purchased a new stake in shares of AdaptHealth during the second quarter worth approximately $96,000. Institutional investors and hedge funds own 82.67% of the company’s stock.

AdaptHealth Stock Performance

AHCO opened at $10.05 on Friday. The firm has a fifty day moving average price of $10.08 and a 200 day moving average price of $9.55. AdaptHealth has a 1 year low of $7.11 and a 1 year high of $11.63. The stock has a market cap of $1.36 billion, a P/E ratio of 18.27, a P/E/G ratio of 1.11 and a beta of 1.71. The company has a debt-to-equity ratio of 1.09, a current ratio of 1.08 and a quick ratio of 0.86.

AdaptHealth (NASDAQ:AHCO) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.24 by ($0.05). The firm had revenue of $820.31 million for the quarter, compared to analyst estimates of $799.62 million. AdaptHealth had a net margin of 2.53% and a return on equity of 4.85%. The firm’s quarterly revenue was up 1.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.15 EPS. Equities research analysts anticipate that AdaptHealth will post 0.88 earnings per share for the current year.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.